Royalty on Licensed Products. In consideration of the grant of the license by Raven hereunder, and subject to the other terms of this Agreement (including the remainder of this Section 5), commencing on [ * ] of [ * ] during the Royalty Term applicable thereto, ImmunoGen shall pay Raven the following royalties based on [ * ] ImmunoGen, its Affiliates or sublicensees on an incremental basis, according to the following rates: For [ * ] Royalty Rate in any Calendar Year During the Term [ * ] ------------------------------------ ------------ [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] For [ * ] of [ * ] Royalty Rate in any Calendar Year During the Term [ * ] ------------------------------------ ------------ [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company's application requesting confidential treatment under Rule 24b-2 of the Securities Exchange Act. As an example, for the avoidance of doubt, in the event that ImmunoGen has [ * ] equal [ * ] the [ * ] would be [ * ] calculated as follows: [ * ] , [ * ] and [ * ] [ * ] . Upon expiration of the Royalty Term in a country with respect to a Licensed Product, ImmunoGen shall thereafter have a paid-up, royalty-free, non-exclusive license under any and all Know-How and Patents of Raven covering such Licensed Patent for purposes of the manufacture, use, sale or import thereof.
Royalty on Licensed Products. Licensee shall pay to UFRF earned royalties calculated as a percentage of Net Sales at the rate of [**]% of Net Sales of Licensed Products.
Royalty on Licensed Products. Licensee shall pay UFRF earned royalties calculated as a percentage of Net Sales during the Royalty Term. Earned royalties are earned as of the earlier of the date the Licensed Product is actually sold and paid for and the date an invoice is sent by Licensee or its Sublicensee(s). Licensee shall pay to UFRF royalties as follows during the Royalty Term:
(a) [*] percent ([*] %) for Net Sales of Licensed Products that are not included in Section 4.4(b).
(b) [*] percent ([*]%) for Net Sales of Licensed Products that are not covered by a Valid Claim, and respecting which there is no Orphan Designation exclusivity in the country of sale. Within [*] after the end of each calendar quarter ending on March 31, June 30, September 30 or December 31, Licensee shall pay amounts owing to UFRF under this Section 4.4 in excess of the amount of minimum royalties paid pursuant to Section 4.5.
Royalty on Licensed Products. Licensee shall pay UFRF, on a country-by-country basis, the following earned royalties:
(I) For all Licensed Products that qualify under Sections 1.10(a), (b), or (d):
(a) [**] percent ([**]%) of Annual Net Sales of Licensed Product(s) in Licensed Field up to $[**] of Net Sales,
(b) [**] percent ([**]%) of Annual Net Sales of Licensed Product(s) in Licensed Field above $[**] and up to $[**], or
(c) [**] percent ([**]%) of Annual Net Sales of Licensed Product(s) in Licensed Field above $[**] of Net Sales; and
Royalty on Licensed Products. Licensee shall pay Penn, on behalf of both Licensors, earned royalties calculated as a percentage of Net Sales. Earned royalties are earned as of the earlier of (i) the date the Licensed Product is actually sold and paid for and (ii) the date an invoice is sent by Licensee, its Affiliates and/or its Sublicensee(s), or as of the date a Licensed Product is transferred to a Third Party for promotional reasons. Licensee shall pay to Penn royalties as follows, on a country-by-country basis:
(a) [**] percent ([**]%) for Net Sales of Licensed Products that are Covered by a Valid Claim of the Patent Rights in the country in which such Licensed Product is sold, which royalty obligation under this Section 4.4(a) shall terminate, on a country-by-country basis, when the Licensed Product is no longer Covered by a Valid Claim of the Patent Rights in the country in which such Licensed Product is sold. In the event of Loss of Market Exclusivity with respect to a Licensed Product in a particular country, the royalty due under this clause Section 4.4(a), if applicable, shall, starting with the calendar quarter following such Loss of Market Exclusivity, be reduced for the remainder of the Royalty Term for such Licensed Product or the period of time that a Loss of Market Exclusivity for such Licensed Product exists in such country, whichever is shorter, to [**] percent ([**]%) for Net Sales of such Licensed Product in such country. For the avoidance of confusion, in each case with respect to sales of a Licensed Product in a particular country, if a royalty reduction for Loss of Market Exclusivity has been applied pursuant to the previous sentence, then a royalty reduction for royalty payments to third parties pursuant to Section 4.4(d) may not be applied.
(b) [**] percent ([**]%) for Net Sales of Licensed Products that are not subject to Section 4.4(a) above, but are sold during a period of Regulatory Exclusivity for such Licensed Product in the country in which such Licensed Product is sold, which royalty obligation under this Section 4.4(b) shall terminate, on a country-by-country basis, when the Licensed Product is no longer sold during a period of Regulatory Exclusivity for such Licensed Product in the country in which such Licensed Product is sold. In the event of Loss of Market Exclusivity with respect to a Licensed Product in a particular country, the royalty due under this clause Section 4.4(b), if applicable, shall, starting with the calendar quarter following such L...
Royalty on Licensed Products. In consideration of the rights herein granted and the ancillary marketing services to be provided hereunder, Company shall pay to Licensor a royalty on sales of Licensed Products ("Percentage Royalty," and with Fixed Royalty, the "Royalty" or "Royalties"), with respect to each Contract Year, in an amount equal to the following percentages of the "Revenue for Licensed Products" (as defined below): Revenue for Licensed Products Percentage Royalty ----------------------------- ------------------ Up to $10 Million 3% Greater than $10 Million 3.5%
Royalty on Licensed Products. BMS will pay to Exscientia a royalty on Net Sales of Licensed Products, on a Licensed Product-by-Licensed Product basis, by BMS, its Affiliates and Sublicensees in the Territory in the Field based on the Net Sales tiers and royalty rates as set forth in the table below (the “Base Royalty Rate”), subject to the reductions and offsets as may be applicable as set forth below in this Section 8.5. Royalties will be paid on the sale of a Licensed Product in a country during the Royalty Term for such Licensed Product in such country. Certain confidential information contained in this document, marked by [****], has been omitted because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential. [****]% of the portion of annual worldwide Net Sales that are [****] in a Calendar Year; [****]% of the portion of annual worldwide Net Sales that are [****] in a Calendar Year; and [****]% of the portion of annual worldwide Net Sales that are [****] in a Calendar Year. For clarity, the Net Sales thresholds in the table above shall be determined on a Licensed Product-by-Licensed Product basis. By way of example, if the aggregate Net Sales of a Licensed Product in the Territory in a particular Calendar Year are $2.2 billion, the amount of the royalties that would be payable for that period (without considering any applicable reductions or offsets under this Section 8.5) would be calculated as follows: [****].
Royalty on Licensed Products. BMS will pay to Schrödinger a royalty on Net Sales of Licensed Collaboration Products, on a Licensed Collaboration Product-by-Licensed Collaboration Product and country-by-country basis, by BMS, its Sublicensees and their Affiliates in the Territory based on the Net Sales tiers and royalty rates as set forth in the table below (the “Base Royalty Rate”) (subject to any offsets or reductions set forth below in this Section 8.4).
Royalty on Licensed Products. In consideration of the grant of rights under Article 5 of this Agreement, AgrEvo agrees to pay 3DP a royalty of [**] on the first [**] of annual Net Sales of each Licensed Product, combined for all uses in the Field. AgrEvo further agrees to pay 3DP a royalty of [**] on the amount of annual Net Sales in excess of [**] of each Licensed Product, combined for all uses in the Field. Notwithstanding the foregoing, royalties pursuant to this Section 6.5 shall be due only for Net Sales of Licensed Products to the extent that they fall within the scope of a Valid Claim of the Compound Patents. No royalties shall be due on Net Sales of a Licensed Product, to the extent that it is covered by a Compound Patent application that AgrEvo chooses not to file or pursue, but that 3DP does choose to file or pursue as described in Section 9.3(a), more than five (5) years from the time that the application was first filed in that country unless and until the Compound Patent actually issues in that country.
Royalty on Licensed Products
